Share
Journal Information
Most cited
Data available in articles published since the year 2014
280
Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysisR. Torres-Castro, L. Vasconcello-Castillo, X. Alsina-Restoy, L. Solis-Navarro, F. Burgos, H. Puppo, J. Vilaró
Pulmonol. 2021;27:328-37
280
Open access
Open Article
183
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effectsD. Visca, C.W.M. Ong, S. Tiberi, R. Centis, L. D’Ambrosio, B. Chen, J. Mueller, P. Mueller, ... D. Goletti
Pulmonol. 2021;27:151-65
183
Open access
Open Article
183
Evaluating the massive underreporting and undertesting of COVID-19 cases in multiple global epicentersH. Lau, T. Khosrawipour, P. Kocbach, H. Ichii, J. Bania, V. Khosrawipour
Pulmonol. 2021;27:110-5
183
Open access
176
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohortsI. Motta, R. Centis, L. D’Ambrosio, J.-M. García-García, D. Goletti, G. Gualano, F. Lipani, F. Palmieri, ... G.B. Migliori
Pulmonol. 2020;26:233-40
176
Open access
148
Tuberculosis, social determinants and co-morbidities (including HIV)R. Duarte, K. Lönnroth, C. Carvalho, F. Lima, A.C.C. Carvalho, M. Muñoz-Torrico, R. Centis
Pulmonol. 2018;24:115-9
148
Open access
146
Medical masks and Respirators for the Protection of Healthcare Workers from SARS-CoV-2 and other virusesMariachiara Ippolito, Filippo Vitale, Giuseppe Accurso, Pasquale Iozzo, Cesare Gregoretti, Antonino Giarratano, Andrea Cortegiani
Pulmonol. 2020;26:204-12
146
Open access
127
The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectivesJ.L. Boechat, I. Chora, A. Morais, L. Delgado
Pulmonol. 2021;27:423-37
127
Open access
122
New drugs and perspectives for new anti-tuberculosis regimensS. Tiberi, M. Muñoz-Torrico, R. Duarte, M. Dalcolmo, L. D’Ambrosio, G.-B. Migliori
Pulmonol. 2018;24:86-98
122
Open access
118
COVID-19 pandemic and non invasive respiratory management: Every Goliath needs a David. An evidence based evaluation of problemsJ.C. Winck, N. Ambrosino
Pulmonol. 2020;26:213-20
118
Open access
108
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic reviewA. Cortegiani, M. Ippolito, M. Greco, V. Granone, A. Protti, C. Gregoretti, A. Giarratano, S. Einav, M. Cecconi
Pulmonol. 2021;27:52-66
108
Open access
Open Article
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
